0
0
7/17/23 at 11:00pm
Organization
Bloomberg
33 words
0
Comments
How a drugstore staple, made in an Indian factory and tainted with an antibiotic-resistant superbug, slipped past the FDA.
You are the first to view
https://www.bloomberg.com/news/features/2023-07-17/eyedrop-recall-2023-and-infections-were-result-of-lack-of-fda-regulation
Create an account
or login to join the discussion